Table 3.
Component | Stock concentration | Volume added | Final concentration | Recommended storage condition |
---|---|---|---|---|
| ||||
WRN-conditioned media | 100 × | 6.5 ml | 65 × | −20 °C freezer |
Base media | 100 × | 3.2 ml* | 32 × | 4 °C fridge |
B27 | 50 × | 200 μl | 1 × | −20 °C freezer |
Nicotinamide | 1 M | 100 μl | 10 mM | −20 °C freezer |
N2 | 100 × | 100 μl | 1 × | −20 °C freezer |
N-acetyl cysteine | 500 mM | 10 μl | 500 μM | −20 °C freezer |
A 83-01 | 500 μM | 10 μl | 500 nM | −20 °C freezer |
Y-27632 dihydrochloride | 10 mM | 10 μl | 10 μM | −20 °C freezer |
SB 202190 | 30 mM | 3.33 μl | 10 μM | −20 °C freezer |
EGF | 250 μg/ml | 2 μl | 50 ng/ml | −20 °C freezer |
human [Leu15]-Gastrin | 100 μM | 1 μl | 10 nM | −20 °C freezer |
Prostaglandin E2 | 10 mM | 2 μl** | 5 nM | −80 °C freezer |
Final volume | 10.14 ml |
Base media consists of Advanced DMEM/F12, 2 mM Glutamax, 10 mM HEPES, 100 units/ml penicillin/streptomycin, described in Table 2. WRN: Wnt, R-spondin 1, Noggin. EGF: epidermal growth factor.
Prostaglandin E2 should be diluted before adding. Make a dilution of 1 μl PGE stock to 349 μl BM. Add 2 μl PGE dilution for 10 ml media.